دانلود کتاب پزشکی دقیق در دیابت- رویکردی چند رشته ای به یک الگوی نوظهور

President Barack Obama, in his State of the Union address on January 20, 2015, had announced “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes — and to give all of us access to the personalized information we need to keep ourselves and our families healthier.” Following the announcement, the National Institute of Health’s director Dr. Francis Collins advocated, “What is needed now is a broad research program to encourage creative approaches to precision medicine, test them rigorously, and ultimately use them to build the evidence base needed to guide clinical practice.” The concept of precision or personalized medicine is not new. Precision medicine, like its precursor, evidence-based medicine, aims at diagnostic specificity. In terms of precision diabetes management, one aims at identifying the underlying pattern of dysglycemia, determining whether the cause is genetic, physiologic, behavioral, and/or pharmacologic; identifying concurrent comorbidities; and matching appropriate management strategies by proper initiation, adjustment, and assessment of clinical response to avoid metabolic and other complications.